Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
0.1230
-0.0067 (-5.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,612,448
Open
0.1292
Bid (Size)
0.1215 (50)
Ask (Size)
0.1299 (20)
Prev. Close
0.1297
Today's Range
0.1201 - 0.1300
52wk Range
0.0955 - 8.280
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum
September 23, 2024
Via
Investor Brand Network
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
September 23, 2024
Via
ACCESSWIRE
Performance
YTD
-89.66%
-89.66%
1 Month
-18.54%
-18.54%
3 Month
-91.58%
-91.58%
6 Month
-57.95%
-57.95%
1 Year
-89.21%
-89.21%
More News
Read More
WHO Review Says No Link Between Mobile Phones, Brain-Cancer Development
September 13, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
September 12, 2024
Via
ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
Via
Investor Brand Network
CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
August 27, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
August 22, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 15, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode
September 03, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
August 27, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Upcoming Virtual Investor CEO Connect Segment
August 22, 2024
Via
Investor Brand Network
What's Going On With CNS Pharmaceuticals Stock Tuesday?
July 30, 2024
Via
Benzinga
Scientists Find Way to Boost Natural Killer Cells Targeting Pediatric Brain Cancer
August 21, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results
August 15, 2024
Via
Investor Brand Network
Exposures
Product Safety
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q2 2024
August 15, 2024
Via
InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
August 06, 2024
Via
Benzinga
Study Uncovers How Brain Tumors Evolve During Treatment
August 05, 2024
Via
Investor Brand Network
Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
August 05, 2024
Via
Benzinga
Microsoft Office Outage: Microsoft Investigates Applications, Services Issue
July 30, 2024
Via
InvestorPlace
SOUN Stock Alert: SoundHound Expands AI Rollout with Stellantis
July 30, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today?
July 30, 2024
Via
InvestorPlace
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
Via
Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM
July 30, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Dow Jumps 200 Points; Pfizer Earnings Top Views
July 30, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.